Carmell Therapeutics Corp... (CTCX)
0.62
0.07 (13.37%)
At close: Jan 14, 2025, 3:59 PM
0.60
-2.60%
After-hours Jan 14, 2025, 07:15 PM EST
undefined% (undefined)
| Bid | 0.58 |
| Market Cap | 12.88M |
| Revenue (ttm) | - |
| Net Income (ttm) | - |
| EPS (ttm) | 0.48 |
| PE Ratio (ttm) | 1.28 |
| Forward PE | n/a |
| Analyst | n/a |
| Ask | 0.61 |
| Volume | 698,425 |
| Avg. Volume (20D) | 10,982,640 |
| Open | 0.53 |
| Previous Close | 0.55 |
| Day's Range | 0.52 - 0.66 |
| 52-Week Range | 0.20 - 4.00 |
| Beta | undefined |
About CTCX
Carmell Therapeutics Corporation focuses on the development of plasma-based bioactive material (PBM) to stimulate tissue repair or growth after injury, disease, and aging. Its lead product candidate is CT-101 bone healing accelerant for tibia fracture healing, foot/ankle fusion, spinal fusion, dental bone graft substitute, and bone void filler; and tissue healing accelerant for androgenetic alopecia and chronic wound healing. The company was foun...
Industry Biotechnology
Sector Healthcare
IPO Date Sep 23, 2021
Employees 9
Stock Exchange NASDAQ
Ticker Symbol CTCX
Website https://www.carmellrx.com
1 week ago ·
Source
+147.98%
Carmell Therapeutics shares are trading higher aft...
Unlock content with
Pro Subscription
3 weeks ago ·
Source
+26.2%
Carmell shares are trading higher after the announced it has entered securities purchase agreement with new and existing investors.
